TrialArthritis & rheumatology (Hoboken, N.J.)2022

Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells.

Nida Meednu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.